Rachel Warren
๐ค SpeakerAppearances Over Time
Podcast Appearances
Chip fabrication is vastly more complex than building cars or rockets.
It requires atomic level precision that takes decades to master.
Some people have pointed to Tesla's 4680 battery cells as a cautionary tale.
You know, this was sort of a project that promised to revolutionize energy, but faced years of delays and did not meet its original performance targets.
But of course, we have seen Musk bring his scale of innovation and I think surprised the naysayers many times before.
So a lot to watch here.
It is certainly a very interesting bet on the future of semiconductor manufacturing.
And I think investors will be excited to watch what happens coming next.
Yeah, I mean, when you focus on secular growth trends, it's very much a tailwind that can carry a company forward, regardless of what the broader economy is doing.
I mean, think of, you know, transformative shifts like the rise of AI, the shift to renewable energy, aging global populations.
When you're investing in these kind of megatrends,
You're betting on a fundamental change in human behavior or technology that's likely to last for a decade or more.
And a lot of those trends really provide a staple foundation that can help investors weather portfolio and market shifts.
It also really allows you to kind of ignore the noise of market cycles and focus on compounding returns through companies that are capturing value in really fast growing sectors.
I'm really excited by the rise of physical artificial intelligence, which is basically, you know, advanced software moving and acting in our world rather than just staying inside a screen.
I mean, you can see this happening right now in healthcare with surgical robotics, right?
I mean, these systems are acting as a superhuman partner for doctors, particularly with the advent of AI offering precision.
This simply isn't possible for a human alone.
I think it's a much larger move towards personalized medicine, where technology helps tailor every treatment to a patient's specific needs.
And, you know, there's a few kind of companies I watch in this space.